Mapi Pharma granted United States patent covering the process for the preparation of fingolimod for multiple sclerosis
Market Watch, The Wall Street Journal, 18 Feb 2014
Accessed on 20 Feb 2014 from http://www.marketwatch.com/story/mapi-pharma-granted-united-states-patent-covering-the-process-for-the-preparation-of-fingolimod-for-multiple-sclerosis-2014-02-18?reflink=MW_news_stmp.